Cardiotoxicity is one of the leading causes of drug attrition during development, and accounts for 22-28% of US post-marketing drug withdrawal. Therefore, developing sensitive in vitro assays assessing drug-induced cardiotoxicity in preclinical and early clinical stages is especially important for drug development.
The TargetMol’s Cardiotoxicity Compound Library, a unique collection of 132 cardiotoxicity inducing compounds, can be used for chemical toxicity evaluation and prediction.
|100 μL * 10 mM (in DMSO)||2183.00|
|250 μL * 10 mM (in DMSO)||3672.00|